Factors identified for detecting polyps on IBD surveillance colonoscopies Gastroenterology Advisor 2d Cancer All sources
At-home Skyrizi induction approved for Crohn's after 56% reached clinical remission at 12 weeks versus 30% on placebo Medical Daily 10:15 Mon, 26 Oct AbbVie Biotech Pharma All sources
AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera Pharmaceutical Technology 16h AbbVie Pharma Biotech
Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial Clinical Trials Arena 09:19 Thu, 22 Oct Teva Sanofi Pharma All sources
